comparemela.com

Latest Breaking News On - Teatorrhoeic hepatosis - Page 12 : comparemela.com

Higher Fibrosis Progression Rate in NAFLD Patients With Diabetes

Patients with type 2 diabetes had about a 2-year faster progression to fibrosis.

National university hospitalSingapore generalUnited statesDaniel huangNational institute of diabetesResearch centerMedscape professional networkNational study cohortUniversity of california san diegoClinical research networkAmerican associationCalifornia san diegoResearch networkNational instituteMedscape professionalNonalcoholic fatty liver disease

Low-Carb Diet Aids Weight Loss in Liver Transplant Recipients

The diet didn t negatively affect serum lipids or renal function.

United statesMohammad siddiquiVirginia commonwealth universityAmerican associationBiliary diseaseAllbladder diseaseTransplantation liverEpatic transplantationRansplantation hepaticLiver transplantationNonalcoholic fatty liver diseaseWeight managementFatty liverTeatorrhoeic hepatosisTeatosis hepatisLiver disease

Noninvasive Tests May Provide Prognostic Value in NAFLD

Fibrosis biomarkers were significantly predictive of event-free survival probability.

United statesFerenc mozesEuropean union horizonUniversity of oxfordInnovative medicines initiativeAmerican associationLiver investigationTesting marker utilityEuropean unionNonalcoholic fatty liver diseaseBiliary diseaseAllbladder diseaseMetabolic syndromeHepatocellular carcinomaLiver cancerHepatocellular cancer

NAFLD Progresses to Cirrhosis in Young and Old at Similar Rate

Risk factors for NAFLD vary with age, but all patients experience similar progression of advanced disease once it develops.

United statesPatricia jonesComoderator mitchella mahmoudMatthewj millerAmerican college of gastroenterologyUniversity of michigan hospital in ann arborInternational classification of diseasesUniversity of miamiDuke university in durhamMichigan hospitalAmerican collegeMichigan medicineInternational classificationPlatelet ratio indexDuke universityNonalcoholic fatty liver disease

AGA Releases Guidelines on Anti-Obesity Medications

New AGA guidelines advise use of anti-obesity medications for weight loss.

United statesEduardo grunvaldAmerican gastroenterological association in gastroenterologyUniversity of california san diegoDrug administrationAmerican gastroenterological associationCalifornia san diegoClinical guidelinesDiabetes mellitusObstructive sleep apneaObstructive sleep apnea hypopnea syndromeSleep apneaSleep disorderDiabetes mellitus type 2Iabetes mellitus type iiType 2 diabetes

vimarsana © 2020. All Rights Reserved.